Presentations included time for Audience Response System (ARS) assisted audience
interaction as well as general question and answer time.
As of 7/9/15
7:00 a.m. – 8:00 a.m. | Registration and Networking Breakfast |
8:00 a.m. – 8:10 a.m. | Welcome and Introductions Thomas F. Gajewski, MD, PhD – University of Chicago |
Session I: Principles of Tumor Immunology 1.25 AMA PRA Category 1 Credits™ |
|
8:10 a.m. – 8:35 a.m. | Immunology 101 for the Non-Immunologist Justin P. Kline, MD – University of Chicago |
8:35 a.m. – 9:00 a.m. | Principles of Targeting Regulatory Checkpoints in Tumor Microenvironment Thomas F. Gajewski, MD, PhD – University of Chicago |
9:00 a.m. – 9:25 a.m. | Melanoma: the Poster Child for Immunotherapy (Cytokines, Checkpoint Inhibitors, Oncolytic Viruses) Jason J. Luke, MD – University of Chicago |
9:25 a.m. – 9:40 a.m. | Break |
Session II: Cancer Immunotherapy Beyond Melanoma – The New Frontier 2.5 AMA PRA Category 1 Credits™ |
|
9:40 a.m. – 10:05 a.m. | Head and Neck Cancer, Mesothelioma, and Lung Cancer Tanguy Seiwert, MD – University of Chicago |
10:05 a.m. – 10:30 a.m. | GI Malignancies Manish Sharma, MD – University of Chicago |
10:30 a.m. – 10:55 a.m. | Breast Cancer Rita Nanda, MD – University of Chicago |
10:55 a.m. – 11:20 a.m. | Immunotherapy for GU Malignancies (Prostate, RCC, Bladder) Walter Stadler, MD – University of Chicago |
11:20 a.m. – 11:45 a.m. | Hematologic Malignancies (CAR-T cells, Vaccines, Checkpoint Inhibitors) Hongtao Liu, MD, PhD – University of Chicago |
11:45 a.m. – 12:00 p.m. | Panel Discussion |
Back to Advances in Cancer ImmunotherapyTM-Illinois General Information